Kanghua Biological
One of the 13 enterprises with full vaccine production capacity in Chengdu Economic and Technological Development Zone, covering an area of 30000 square meters.
Launch date
Market cap
$833m
Enterprise valuation
$752m (Public information from Sep 2024)
Share price
CNY45.01 300841.SZ
Chengdu Sichuan (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.0b | 1.3b | 1.4b | 1.6b | 1.9b | 2.2b | 2.4b |
| % growth | 87 % | 24 % | 12 % | 9 % | 20 % | 14 % | 12 % |
| EBITDA | 502m | 953m | 767m | 677m | 890m | 997m | 1.1b |
| % EBITDA margin | 48 % | 74 % | 53 % | 43 % | 47 % | 46 % | 46 % |
| Profit | 408m | 829m | 598m | 509m | 704m | 791m | 885m |
| % profit margin | 39 % | 64 % | 41 % | 32 % | 37 % | 37 % | 37 % |
| EV / revenue | 27.1x | 14.8x | 7.8x | 6.6x | 3.6x | 3.2x | 2.8x |
| EV / EBITDA | 56.0x | 20.1x | 14.8x | 15.3x | 7.7x | 6.8x | 6.2x |
| R&D budget | 58.3m | 78.9m | 180m | 253m | - | - | - |
| R&D % of revenue | 6 % | 6 % | 12 % | 16 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Growth Equity VC | |
| N/A | $149m | IPO | |
| Total Funding | - | ||
Related Content
Recent News about Kanghua Biological
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
